Skip to main navigation Skip to search Skip to main content

Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial

  • TOURMALINE-MM3 study group

Research output: Contribution to journal › Article › peer-review

223   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology